...
首页> 外文期刊>Journal of Medicinal Chemistry >The Druggability of Solute Carriers
【24h】

The Druggability of Solute Carriers

机译:溶质载体的可耐药性

获取原文
获取原文并翻译 | 示例

摘要

The transport of materials across membranes is a vital process for all aspects of cellular function, including growth, metabolism, and communication. Protein transporters are the molecular gates that control this movement and serve as key points of regulation for these processes, thus representing an attractive class of therapeutic targets. With more than 400 members, the solute carrier (SLC) membrane transport proteins are the largest family of transporters, yet, they are pharmacologically underexploited relative to other protein families and many of the available chemical tools possess suboptimal selectivity and efficacy. Fortuitously, there is increased interest in elucidating the physiological roles of SLCs as well as growing recognition of their therapeutic potential. This Perspective provides an overview of the SLC superfamily, including their biochemical and functional features, as well as their roles in various human diseases. In particular, we explore efforts and associated challenges toward drugging SLCs, as well as highlight opportunities for future drug discovery.
机译:跨膜的材料的运输是细胞功能的所有方面的重要过程,包括生长,新陈代谢和沟通。蛋白质转运蛋白是控制该运动的分子栅极,并用作这些过程的关键调节点,从而代表一种吸引人的治疗靶标。拥有400多名成员,溶质载体(SLC)膜输送蛋白是最大的运输蛋白家族,但它们是相对于其他蛋白质家族的药理学望远镜,而且许多可选的化学工具具有次优选择性和功效。偶尔,阐明了阐明了SLC的生理作用以及日益增长的治疗潜力的兴趣增加。这种观点提供了SLC超家族的概述,包括它们的生化和功能特征,以及它们在各种人类疾病中的作用。特别是,我们探讨了努力和相关挑战对吸毒的SLC,以及突出未来药物发现的机会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号